RAPT
RAPT Therapeutics, Inc.
Key Financials
Revenue
$0
↓ 100.0%
Net Income
$-129865000
↓ 11.2%
Operating Income
$-136101000
↓ 7.1%
Total Liabilities
$50.4M
↑ 91.8%
Cash & Equivalents
$169.7M
↑ 257.5%
EPS (Diluted)
$-3.19
↓ 4.6%
Total Assets
$240.3M
↑ 38.7%
Shareholders' Equity
$189.9M
↑ 29.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 3/18/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RAPT |
| Company Name | RAPT Therapeutics, Inc. |
| CIK | 1673772 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (650) 489-9000 |